All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.

Matthias A Fante,Dennis C Harrer, Barbara Zartner,Florian Lüke,Stephanie Mayer,Karin Menhart,Albrecht Reichle,Wolfgang Herr,Martin Vogelhuber,Daniel Heudobler

Frontiers in oncology（2023）

引用 0|浏览4

暂无评分

摘要

TEPIP demonstrated competitive efficacy with a tolerable safety profile in a highly palliative cohort of patients with difficult-to-treat PTCL. The all-oral application, which makes outpatient treatment possible, is particularly noteworthy.

查看译文

关键词

chemotherapy,all-oral,low-dose,well-tolerated,t-cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要